LOADING

Type to search

Business Entrepreneur Health Science

Dr. Amritphale is Leading the Field of Artificial Intelligence for Heart Health

Share

Raymond Gilmore, Orlando, Miami, 05/11/2021

Top cardiologist Dr. Amod Amritphale is revolutionizing heart health care with artificial intelligence and is leading researchers into the future of medicine. “Women’s heart health is grossly under-researched and this program can be used for helpful diagnostics and treatment outcomes,” he says.

Cardiovascular disease is the one of the leading threats to women, claiming approximately one woman per minute or 1 in 3 women every year. “Many women have significant risk factors that could be used to point to heart disease developing in them, but there is a lack of awareness for the symptoms and patients could overlook them,” Dr. Amritphale informs.

“We have to develop better advocacy for women’s heart health because there are many preventable early deaths if we could catch the signs early,” He says. Many women may have a treatable heart issue, but they may think it is secondary to an  anxiety attack or stress when in reality it may point to more ominous disease processes. As the director of the Women’s Heart Program at the University of South Alabama and the University Hospital in Mobile, Alabama, and as an Interventional Cardiologist, he can provide extensive literature for highlighting the issue. “I have taken up the onus to educate women of all ages to teach them the signs of heart disease and preventive methods so that they can seek help before it is too late,” he says. 

What’s different about Dr. Amritphale’s methodology is that not only is he advocating for, treating, and making preventative changes for women and their risk of heart disease, but he is also doing so using computer algorithm programs that he designed. He is also the Director of Cardiovascular Research at the University. “I am involved in extensive research. My focus of research is “Use of Machine learning and Artificial Intelligence in making better decisions in the field of medicine” and I am also using national databases like HCUP. I use this program to develop algorithms that help identify patients who are at increased risk of bad outcomes so that we can preemptively identify them and help them before the worsening of disease processes occur. This helps people live better and live longer and prevents untimely or early death,” Dr. Amritphale says. This method is uniquely his, and he is revolutionizing how people can detect, treat, and determine cardiovascular treatment success with these programs he uses in daily practice. 

With various cardiovascular treatments and surgical processes, Dr. Amritphale is able to detect and predict whether or not patients will need to return for an unplanned readmission with his artificial intelligence computer algorithm. From the abstract from his academic study, he and his team of researchers had successful results. “We present a novel deep neural network-based artificial intelligence prediction model to help identify a subgroup of patients undergoing carotid artery stenting who are at risk for short term unplanned readmissions. Prior studies have attempted to develop prediction models but have used mainly logistic regression models and have low prediction ability. The novel model presented in this study boasts 79% capability to accurately predict individuals for unplanned readmissions post carotid artery stenting within 30 days of discharge,” (Amritphale, A., Chatterjee, R., Chatterjee, S. et al. Predictors of 30-Day Unplanned Readmission After Carotid Artery Stenting Using Artificial Intelligence. Adv Ther (2021). https://doi.org/10.1007/s12325-021-01709-7). 

As an international authority and a pioneer in this field of healthcare, his innovation is the next step to making sure women’s heart health is properly researched, recognized, diagnosed, and treated. His advocacy and computer algorithm are seventy-nine percent accurate to determine the healing, successes of a treatment, and any risk factors that would bring the patient back within thirty days after cardiac stenting surgery.

With this incredible research and innovation, Dr. Amritphale can truly be considered as the ‘Father of Modern Artificial Intelligence Medicine’ and his recently published work in the journal Advances in Therapy will be a boon for all patients.

Leave a Comment

Your email address will not be published. Required fields are marked *